Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,881,974
-
Share change
-
+9,298,255
-
Total reported value
-
$135,876,928
-
Put/Call ratio
-
150%
-
Price per share
-
$3.23
-
Number of holders
-
80
-
Value change
-
+$34,847,365
-
Number of buys
-
61
-
Number of sells
-
17
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q1 2021
As of 31 Mar 2021,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,881,974 shares.
The largest 10 holders included
BVF INC/IL, Consonance Capital Management LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., AIGH Capital Management LLC, Tri Locum Partners LP, GUARDIAN POINT CAPITAL, LP, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.